News tagged with neutralizing antibodies

HIV uses several strategies to escape immune pressure

Medicine & Health / HIV & AIDS

Sep 19, 2009 | 5 / 5 (3) | 0

A study of how HIV mutates in response to immune system pressure by Emory Vaccine Center researchers shows that the virus can take several escape routes, not one preferred route.

Study offers insights into failed HIV-1 vaccine trial

Medicine & Health / HIV & AIDS

Jul 20, 2009 | 5 / 5 (1) | 1

Following the disbandment of the STEP trial to test the efficacy of the Merck HIV-1 vaccine candidate in 2007, the leading explanation for why the vaccine was ineffective - and may have even increased susceptibility to acquiring ...

Scientists gain insight into HIV vaccine failure

Medicine & Health / HIV & AIDS

Jul 20, 2009 | 3.5 / 5 (4) | 0

A team of researchers from The Wistar Institute and the University of Pennsylvania reports new evidence refuting a popular hypothesis about the highly publicized failure in 2007 of the Merck STEP HIV vaccine study that cast ...

New technology opens gateway to studying HIV-specific neutralizing antibodies

Medicine & Health / HIV & AIDS

Mar 16, 2009 | not rated yet | 0

Many scientists believe a vaccine that prevents HIV infection will need to stimulate the body to make neutralizing antibodies, infection-fighting proteins that prevent HIV from entering immune cells. Previous research has ...

Scientists Find Rare, Potent Antibody to HIV-1

Medicine & Health / HIV & AIDS

Feb 23, 2009 | 5 / 5 (4) | 0

(PhysOrg.com) -- Scientists at Duke University Medical Center have for the first time isolated an important antibody in human serum that could potentially play a key role in the design of an AIDS vaccine. The research appears ...

Scientists identify genetic link that may neutralize HIV

Medicine & Health / HIV & AIDS

Sep 04, 2008 | 4.5 / 5 (24) | 0

Scientists from the Gladstone Institute of Virology and Immunology (GIVI) and the National Institutes of Allergy and Infectious Diseases (NIAID) have identified a gene that may influence the production of antibodies that ...

NIAID will not move forward with the PAVE 100 HIV Vaccine Trial

Medicine & Health / HIV & AIDS

Jul 17, 2008 | not rated yet | 0

After soliciting and considering broad input from the scientific and HIV advocacy communities, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has determined ...